1. Watch our video:
See how KPMG Covered Entity 360 can help get greater control of your 340B inquiry process while improving coordination and efficiency.
Get greater control of your 340B inquiry process
Navigating the complexities of Covered Entity (340B) inquiries presents multifaceted challenges: obscured visibility, error-prone manual tracking, inconsistent responses, and growing communication hurdles as stakeholders increase.
The KPMG Covered Entity 360 accelerator is an industry first - the only automated tool on the market designed for the efficient management of 340B inquiries. This centralized platform transforms the 340B inquiry process by replacing spreadsheets, SharePoint documents, and shared group email inboxes with automated workflows. It provides users with a comprehensive 360-degree view, enhancing visibility and consistency while building a historical record that is vital for informed strategic decision-making.
Potential benefits of KPMG Covered Entity 360
The benefits of KPMG Covered Entity 360 platform include:
1
2
3
4
5
Our KPMG Covered Entity 360 is Intuitive and Easy-to-Use
The KPMG Covered Entity 360 accelerator centralizes all 340B inquiry-related data into a single location, featuring intuitive interfaces and dashboards that simplify processes and provide multiple stakeholders—from legal teams to executive leadership—with a unified source of truth to foster collaboration.
Users can continuously monitor the status and milestones achieved in each case, while receiving timely reminders and notifications to ensure smooth operations and adherence to complex policies.
Streamline your approach to case management inquiries
See how KPMG Covered Entity 360 can help get greater control of your 340B inquiry process while improving coordination and efficiency.
At KPMG, we help commercial drug manufacturers streamline and strengthen their management of covered entity case inquiries through consistent, secure, and auditable workflows that improve collaboration across legal, compliance, and operational teams. With unified access to inquiry data, automated task routing, and AI-enabled response generation, our solution enhances visibility, ensures policy adherence, and supports strategic decision-making through robust analytics. What sets us apart is our deep life sciences expertise, proven track record in regulatory transformation, and a flexible, tech-agnostic approach.
A leading global life sciences company worked with KPMG to help address its fragmented and cumbersome 340B inquiry process that was creating visibility gaps, inconsistent responses, and operational delays. The KPMG Covered Entity 360 accelerator helped transform the process, introducing automation to ensure consistency and efficiency, centralization to improve visibility and reduce error, greater data security, and analytics tools for informed strategic planning.
Start the conversation today!